FindTrial
Sign In

Clinical outcomes of low concentration atropine to control the progression of myopia

Clinical outcomes of low concentration atropine to control the progression of myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036530
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ametropia

Interventions

1:0.01%atropine
2:0.02%atropine
3:glassses

Sponsors

Department of Ophthalmology, Eye and ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 14 Years

Inclusion criteria

Inclusion criteria: Aged5-14, diagnosis of ametropia.

Exclusion criteria

Exclusion criteria: Have ocular or systemic disease.

Design outcomes

Primary

MeasureTime frame
Visual acuity;Refraction;Intraocular pressure;accomodation amplitude;accomodation sensitivity;pupil diameter;Ocular axial length;—

Countries

China

Contacts

Public ContactJing Zhao
zhaojing_med@163.com+86 021-64377134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026